.

New Deal

New Deal

Announced

13 Jun 2012

Completed

14 Aug 2012

PROXIMAGEN GROUP PLC / UPSHER-SMITH LABORATORIES INC / Scheme / Public / £167m

Financials

Edit Data

Transaction Value£140m

Consideration TypeCash, Contingent Deferred Consideration

Capital Owned16%

Capital Bid For84%

EV/Sales-

EV/EBITDA-

Share Price Premium-

One Off Charge-

target

Proximagen Group

bidder

Upsher-smith Laboratories

Sources

Edit

Tags

Edit

research & development

pharmaceuticals

pharmaceuticals research & development

Pharmaceuticals

United Kingdom

Public

Scheme

Completed

Friendly

Single Bidder

Synopsis

Edit

Service Providers (4)

Dealmakers

brokers

Cenkos Securities

financial advisors

Wg Partners

financial advisors

Cenkos Securities

financial advisors

Jp Morgan

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US